Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

JOHNSON & JOHNSON

(JNJ)
  Report
Delayed Nyse  -  04:00 2022-09-23 pm EDT
166.72 USD   +0.32%
09/22US Stocks End Lower Thursday Despite Healthcare Gains
MT
09/22US Stocks End Lower Thursday Despite Surge in Healthcare Shares
MT
09/22Johnson & Johnson - Diversifying Our Health Workforce through the Impact of AIM
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société JOHNSON & JOHNSON
09/22Johnson & Johnson - Diversifying Our Health Workforce through the Impact of AIM
AQ
09/22Over 200 Inmates, Prison Officers Vaccinated Against Covid-19
AQ
09/21J&J's talc Texas two-step called out by victims
AQ
09/20No, Covid Vaccines Don't Cause Body to Produce Toxic Spike Proteins That Cause Cancer
AQ
09/20Johnson & Johnson Opens State-of-the-Art Science and Technology Campus in San Francisco..
BU
09/19JOHNSON & JOHNSON : Debuts a Groundbreaking R&D Facility in the San Francisco Bay Area
PU
09/14Dow stabilizes following worst sell-off since 2020
AQ
09/14Starbucks, Johnson & Johnson rise; Nucor, Union Pacific fall
AQ
09/14JOHNSON & JOHNSON : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/14Johnson & Johnson Announces $5 Billion Share Repurchase Program
BU
09/13Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
BU
09/13Sahpra Confirms Second Death Linked to J&J Covid-19 Vaccine
AQ
09/09Janssen Pharmaceutical - TREMFYA Demonstrates Higher Rates of Complete Skin Clearance w..
AQ
09/08JOHNSON & JOHNSON : TREMFYA®▼ (guselkumab) Demonstrates Higher Rates of Complete Ski..
PU
09/08NON-DEBTOR PARENTS BEWARE : Bankruptcy Court Denies Extending MDL Injunction
AQ
09/06JOHNSON & JOHNSON : Biosense Webster Launches the OCTARAY™ Mapping Catheter with TRU..
PU
09/01New Hampshire to get $40.5M in opioids case settlement
AQ
09/01JOHNSON & JOHNSON : Statement on New Hampshire Opioid Settlement Agreement
PU
09/01ACommerce and Johnson & Johnson Launch Sustainable Packaging Solution for a Better E-co..
AQ
08/29Somalia Receives 1.6 Million J&J Covid-19 Vaccine Doses From Sweden and the Czech Repub..
AQ
08/25The Janssen Pharmaceutical Companies - U.S. FDA Approves IMBRUVICA (ibrutinib) as First..
AQ
08/25Janssen Marks First Approval Worldwide for TECVAYLI (teclistamab) with EC Authorisation..
AQ
08/25LIDDS AB (publ) Interim Report January – June 2022
AQ
08/24JOHNSON & JOHNSON : U.S. FDA Approves IMBRUVICA® (ibrutinib) as First and Only BTKi Treatm..
PU
08/24Johnson & Johnson Appoints Larry Merlo as Non-Executive Chair Designate of Planned New ..
BU
08/18Evotec - PAN-TB Collaboration to Advance Investigational Tuberculosis Drug Regimens to ..
AQ
08/18Johnson & Johnson Stopping All Sales Of Talcum-based Baby Powder
AQ
08/17JOHNSON & JOHNSON : PAN-TB Collaboration to Advance Investigational Tuberculosis Drug Regi..
PU
08/12Johnson & Johnson Ends Global Sales of Cancer-Causing Baby Powder Amid Increased Scruti..
PR
08/12J&J to end sales of baby powder with talc globally next year
AQ
08/12Johnson & Johnson to end global sales of talc-based baby powder in 2023
AQ
08/11J&J to end sales of talc-based powder worldwide in 2023
AQ
08/11JOHNSON & JOHNSON : Consumer Health to Transition Global Baby Powder Portfolio to Cornstar..
PU
08/11J&J COVID vaccine factory forced to trash even more doses
AQ
08/09Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Co..
BU
08/08Mathai Mammen, M.D., Ph.D., Leaves Position as Executive Vice President, Pharmaceutical..
BU
08/05The Janssen Pharmaceutical Companies - European Commission Approves IMBRUVICA (ibrutini..
AQ
08/02Johnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conferen..
BU
08/01JOHNSON & JOHNSON : STELARA® (ustekinumab) Approved by the U.S. Food and Drug Administrati..
PU
07/29JOHNSON & JOHNSON MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
07/29Raphe Pharmaceutique Vendor Generic & OTC Self Care Contract Manufacturing Pharmaceutic..
AQ
07/27Janssen Announces New Data Supporting Safety and Efficacy of RYBREVANT and Lazertinib C..
AQ
07/26JOHNSON & JOHNSON : Janssen Announces New Data Supporting Safety and Efficacy of RYBREVANT..
PU
07/25Janssen Receives Positive CHMP Opinion for Novel Bispecific Antibody TECVAYLI (teclista..
AQ
07/25Greenback to hit US firms as Wall Street feels chill
AQ
07/20JOHNSON & JOHNSON : 2022 Second-Quarter Earnings Transcript
PU
07/20MORE TEARS : Johnson & Johnson cuts sales and profit forecasts
AQ
07/19Johnson & Johnson's Executive Vice President, General Counsel Michael Ullmann to Retire..
AQ
07/19Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2022
AQ
07/19Strong Q2 at J&J, but outlook cut again due to dollar's rise
AQ
07/19JOHNSON & JOHNSON : 2Q22 Other Financial Disclosures (Excel)
PU
07/19JOHNSON & JOHNSON : What You Need to Know About Johnson & Johnson's 2022 Second-Quarter Ea..
PU
07/19JOHNSON & JOHNSON : 2022 Second-Quarter Press Release & Supplemental Schedules
PU
07/19JOHNSON & JOHNSON : 2022 Second-Quarter Infographic & Earnings Presentation
PU
07/19JOHNSON & JOHNSON : 2Q22 Other Financial Disclosures (PDF)
PU
07/19JOHNSON & JOHNSON : Q2 Earnings Snapshot
AQ
07/19Johnson & Johnson Reports Q2 2022 Results
BU
07/18Johnson & Johnson's Executive Vice President, General Counsel Michael Ullmann to Retire..
BU
07/08Network with Johnson & Johnson, Springboard, BSI, AstraZeneca and Many More at the Wear..
AQ
06/30Janssen Announces U.S. FDA Breakthrough Therapy Designation Granted for Talquetamab for..
AQ
06/29NHIF, Janssen Kenya Sign MOU to Enhance Prostrate Cancer Drugs Access
AQ
06/27Janssen Receives Positive CHMP Opinion for IMBRUVICA (ibrutinib) in a Fixed-Duration Co..
AQ
06/24JOHNSON & JOHNSON : Janssen Receives Positive CHMP Opinion for IMBRUVICA® (ibrutinib) in a..
PU
06/23JOHNSON & JOHNSON : Renews Commitment to Fight Neglected Tropical Diseases, Investing in B..
PU
06/20Johnson & Johnson Opens First Satellite Center for Global Health Discovery in Asia Paci..
PR
06/16Federal Government Removes Vaccination Requirements For Domestic And Out-Bound Travel
AQ
06/15Top Local Changemakers Addressing Health Equity Gaps Across the U.S. Named Johnson & Jo..
AQ
06/15Evotec enters a drug discovery collaboration with Janssen
AQ
06/10JOHNSON & JOHNSON : New IMBRUVICA® (ibrutinib) Data in Fixed-Duration Combination Regimen ..
PU
06/10JOHNSON & JOHNSON : Janssen Presents Updated Results Evaluating First-in-Class GPRC5D Bisp..
PU
06/10Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
AQ
06/08COVID-19 VACCINES : No Sharing Of Know-How
AQ
06/08Johnson & Johnson Releases 2021 Health for Humanity Report Highlighting Performance on ..
PR
06/08Janssen Presents Initial Results from the Phase 2 RAGNAR Study of BALVERSA (erdafitinib..
AQ
06/08Royal Philips - Willem Appelo to succeed Sophie Bechu as Philips Chief Operations Offic..
AQ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on JOHNSON & JOHNSON